PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
9.16%
Revenue growth at 50-75% of TSM's 14.79%. Martin Whitman would worry about competitiveness or product relevance.
9.87%
Gross profit growth at 50-75% of TSM's 17.44%. Martin Whitman would question if cost structure or brand is lagging.
9.29%
EBIT growth 50-75% of TSM's 18.39%. Martin Whitman would suspect suboptimal resource allocation.
9.29%
Operating income growth at 50-75% of TSM's 18.39%. Martin Whitman would doubt the firm’s ability to compete efficiently.
3.79%
Net income growth under 50% of TSM's 18.50%. Michael Burry would suspect the firm is falling well behind a key competitor.
4.21%
EPS growth under 50% of TSM's 18.49%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
3.19%
Diluted EPS growth under 50% of TSM's 18.49%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.24%
Share change of 0.24% while TSM is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
0.24%
Slight or no buyback while TSM is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-0.24%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-43.36%
Negative OCF growth while TSM is at 21.79%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-48.06%
Negative FCF growth while TSM is at 23.03%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
547.35%
10Y revenue/share CAGR above 1.5x TSM's 333.16%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
205.23%
5Y revenue/share CAGR 1.25-1.5x TSM's 143.22%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
117.67%
3Y revenue/share CAGR similar to TSM's 109.26%. Walter Schloss would assume both companies experience comparable short-term cycles.
503.88%
10Y OCF/share CAGR 1.25-1.5x TSM's 438.39%. Bruce Berkowitz would confirm if the firm's long-term capital allocation yields better cash returns.
185.61%
5Y OCF/share CAGR at 50-75% of TSM's 253.41%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
204.05%
3Y OCF/share CAGR similar to TSM's 191.15%. Walter Schloss might see both benefiting from a rising tide or parallel expansions.
1243.02%
Net income/share CAGR above 1.5x TSM's 468.62% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
291.49%
5Y net income/share CAGR 1.25-1.5x TSM's 212.35%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
95.27%
3Y net income/share CAGR 50-75% of TSM's 177.91%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
481.97%
10Y equity/share CAGR above 1.5x TSM's 305.78%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
284.93%
5Y equity/share CAGR above 1.5x TSM's 91.38%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
144.83%
3Y equity/share CAGR above 1.5x TSM's 72.55%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
41.17%
Stable or rising mid-term dividends while TSM is cutting. John Neff sees an edge in consistent payouts vs. the competitor.
7.12%
Our short-term dividend growth is positive while TSM cut theirs. John Neff views it as a comparative advantage in shareholder returns.
10.26%
AR growth well above TSM's 17.77%. Michael Burry fears inflated revenue or higher default risk in the near future.
5.63%
Inventory growth well above TSM's 0.41%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
5.13%
Asset growth at 50-75% of TSM's 6.84%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
12.27%
1.25-1.5x TSM's 9.63%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
-7.68%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
12.69%
R&D growth drastically higher vs. TSM's 8.39%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
5.89%
SG&A declining or stable vs. TSM's 25.38%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.